VCs fund new cardiac system

Inovise Medical, a privately held cardiac diagnostic company, has raised $12.5 million in new capital to support development of technology that combines electrical and sound information to evaluate cardiac conditions associated with coronary artery disease, left ventricular hypertrophy, acute coronary syndrome, and heart failure. This latest round of financing, which was led by new investors MDS Capital and TAT Capital Partners, brings the total equity investment in the firm to $22 million. The company could release its first product later this year. Managers from Hewlett-Packard founded Inovise Medical in 1997.